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Abstract 
Background: 5-Aminovaleric acid (5AVA) is an important five-carbon platform chemical that can be used for the 
synthesis of polymers and other chemicals of industrial interest. Enzymatic conversion of l-lysine to 5AVA has been 
achieved by employing lysine 2-monooxygenase encoded by the davB gene and 5-aminovaleramidase encoded 
by the davA gene. Additionally, a recombinant Escherichia coli strain expressing the davB and davA genes has been 
developed for bioconversion of l-lysine to 5AVA. To use glucose and xylose derived from lignocellulosic biomass as 
substrates, rather than l-lysine as a substrate, we previously examined direct fermentative production of 5AVA from 
glucose by metabolically engineered E. coli strains. However, the yield and productivity of 5AVA achieved by recom-
binant E. coli strains remain very low. Thus, Corynebacterium glutamicum, a highly efficient l-lysine producing microor-
ganism, should be useful in the development of direct fermentative production of 5AVA using l-lysine as a precursor 
for 5AVA. Here, we report the development of metabolically engineered C. glutamicum strains for enhanced fermenta-
tive production of 5AVA from glucose.
Results: Various expression vectors containing different promoters and origins of replication were examined for 
optimal expression of Pseudomonas putida davB and davA genes encoding lysine 2-monooxygenase and delta-
aminovaleramidase, respectively. Among them, expression of the C. glutamicum codon-optimized davA gene fused 
with His6-Tag at its N-Terminal and the davB gene as an operon under a strong synthetic H36 promoter (plasmid 
p36davAB3) in C. glutamicum enabled the most efficient production of 5AVA. Flask culture and fed-batch culture of 
this strain produced 6.9 and 19.7 g/L (together with 11.9 g/L glutaric acid as major byproduct) of 5AVA, respectively. 
Homology modeling suggested that endogenous gamma-aminobutyrate aminotransferase encoded by the gabT 
gene might be responsible for the conversion of 5AVA to glutaric acid in recombinant C. glutamicum. Fed-batch 
culture of a C. glutamicum gabT mutant-harboring p36davAB3 produced 33.1 g/L 5AVA with much reduced (2.0 g/L) 
production of glutaric acid.
Conclusions: Corynebacterium glutamicum was successfully engineered to produce 5AVA from glucose by optimiz-
ing the expression of two key enzymes, lysine 2-monooxygenase and delta-aminovaleramidase. In addition, produc-
tion of glutaric acid, a major byproduct, was significantly reduced by employing C. glutamicum gabT mutant as a host 
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Background
As a result of increasing pressure on the environment, 
bio-based production of chemicals, fuels, and materials 
from renewable non-food biomasses has been attracting 
much attention [1]. To make such bio-based processes 
competitive, microorganisms have been metabolically 
engineered for production of fuels [2–4], amino acids [5–
9], polymers [10–12], and other chemicals of industrial 
importance [13–15]. It is expected that more chemicals 
and materials of petrochemical origin will be produced 
through bio-based route employing microorganisms 
developed by systems metabolic engineering [16, 17].
A non-proteinogenic ω-amino acid, 5-aminovaleric 
acid (5AVA), has attracted attention as a five carbon 
(C5) platform chemical because of its potential in poly-
mer synthesis [18–21]. 5AVA can be used to produce 
δ-valerolactam (2-piperidone) via intramolecular dehy-
drative cyclization and can be further processed for syn-
thesis of bio-based nylons, such as nylon-5 and nylon-6,5 
[18, 20]. Enzymatic conversion of l-lysine to 5AVA has 
been achieved by employing lysine 2-monooxygenase 
(E.C. 1.13.12.2, encoded by the davB gene) and 5-amino-
valeramidase (E.C. 3.5.1.30, encoded by the davA gene) 
[19]. We recently reported the development of a whole-
cell bioconversion process for conversion of l-lysine to 
5AVA by employing recombinant Escherichia coli strains 
expressing lysine 2-monooxygenase and 5-aminovaler-
amidase as whole cell biocatalysts [20, 21]. However, it is 
obviously desirable to use glucose derived from non-food 
lignocellulosic biomass as a substrate rather than l-lysine 
[1]. There have been reports on the development of met-
abolically engineered microorganisms for the production 
of C3 and C4 ω-amino acids, such as β-alanine [22] and 
γ-aminobutyrate [23], from glucose. We and others also 
examined the possibility of producing the C5 ω-amino 
acid 5AVA by metabolic engineering of E. coli, but the 
yield and productivity of 5AVA remain very low [18, 20]. 
Thus, it is necessary to develop a new strategy for more 
efficient production of 5AVA.
Corynebacterium glutamicum is an organism widely 
used for the production of amino acids, proteins, mon-
omers for plastic materials, and compounds for cos-
metics [24, 25]. Additionally, C. glutamicum has been 
successfully engineered to produce a different C5-plat-
form chemical, cadaverine (1,5-pentanediamine), and 
was shown to be a promising host for producing this 
chemical using different carbon sources, such as glucose 
and xylose [26–30]. Because C. glutamicum strains capa-
ble of producing l-lysine at very high levels have already 
been commercialized, we decided to exploit C. glutami-
cum as a host strain for the production of 5AVA.
In this study, we designed and introduced a synthetic 
pathway for the production of 5AVA into an l-lysine-
overproducing C. glutamicum strain. The synthetic 
pathway consists of two key enzymes, lysine 2-monoox-
ygenase encoded by the davB gene and 5-aminovaler-
amidase encoded by the davA gene, responsible for the 
conversion of l-lysine to 5AVA. Various expression sys-
tems including vectors and promoters were examined for 
the most efficient production of 5AVA in C. glutamicum. 
A reaction responsible for unexpected formation of glu-
taric acid as a major byproduct was identified and sub-
sequently deleted. The final engineered C. glutamicum 
strain was used for enhanced production of 5AVA by fer-
mentation with much reduced glutaric acid.
Results and discussion
Construction of the 5AVA synthesis pathway in C. 
glutamicum by expressing the davAB genes under the 
control of the tac promoter
Although 5AVA exists as an intermediate in amino acid 
degradation pathways in Pseudomonads, metabolic 
engineering for enhanced production of 5AVA requires 
strong metabolic flux from the chosen intermediate 
metabolite toward 5AVA as indicated by many success-
ful examples of systems metabolic engineering [16, 17]. 
Recombinant E. coli strains employing the davAB genes 
from the l-lysine catabolic pathway of Pseudomon-
ads were previously shown to produce 5AVA, although 
at low yield and productivity [18, 21]. Because E. coli 
strains have a relatively low capacity to provide l-lysine 
as a precursor for 5AVA, high-level production of 5AVA 
could not be achieved in recombinant E. coli strains even 
though the l-lysine catabolic pathway via 5-aminovalera-
mide provides the shortest route from l-lysine to 5AVA 
[18, 21]. Thus, C. glutamicum, the well-known, highly 
efficient l-lysine producing bacterium, was selected as a 
host strain for 5AVA production in this study to provide 
strong metabolic flux from glucose to l-lysine, the direct 
precursor of 5AVA [5, 6]. This is strategically advanta-
geous for producing compounds using l-lysine as a direct 
precursor.
To extend the metabolic flux from glucose toward 
5AVA beyond l-lysine (Fig.  1a), P. putida ATCC 12633 
strain. The metabolically engineered C. glutamicum strains developed in this study should be useful for enhanced 
fermentative production of the novel C5 platform chemical 5AVA from renewable resources.
Keywords: 5-Aminovaleric acid, Corynebacterium glutamicum, l-Lysine, Metabolic engineering, Glutaric acid
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davAB genes [20, 21] were cloned in two different E. coli-
C. glutamicum shuttle vectors (Additional file 5: Table S1; 
Fig. 1b) and expressed in C. glutamicum BE strain (KCTC 
12390BP). In plasmids pKCA212davAB and pJS30 
(Fig. 1b), the davA and davB genes were organized in an 
operon and expressed under the control of the tac pro-
moter, with an additional lacUV5 ribosome-binding site 
(tttcacacaggaaaca) for the davB gene residing between 
the coding sequences of the two genes. Plasmid pKCA-
212davAB was constructed based on an in-house shuttle 
vector, pKCA212-MCS, whereas pJS30 was derived from 
pEKEx1 [31]. Plasmid pEKEx1 contains a pBL1 origin 
of replication, having ~30 copy numbers per cell in C. 
glutamicum [32], and pKCA212-MCS contains a pCC1 
origin of replication, also having ~30 to ~40 copies per 
cell [33]. It was found that C. glutamicum BE could pro-
duce 17.2  g/L l-lysine (yield of 325  mmol/mol glucose) 
in shake-flask cultivation in 44  h (Fig.  2). It was found 
through HPLC analysis of metabolites excreted into 
culture medium that expression of the davAB genes in 
C. glutamicum BE resulted in conversion of l-lysine to 
5AVA, whereas the non-engineered strain did not con-
vert any l-lysine into 5AVA (Fig. 2).
Slightly decreased l-lysine production was observed 
in recombinant C. glutamicum BE strains expressing 
the davAB genes, although l-lysine was still the major 
product in both engineered strains tested. Expression 
of the davAB genes using the shuttle vector pEKEx1 
(pJS30) was more effective at producing 5AVA than 
using pKCA212-MCS (pKCA212davAB) (Fig. 2). The C. 
glutamicum BE strain harboring pKCA212davAB pro-
duced 13.4  g/L l-lysine (yield of 271.2  mmol/mol) and 
58 mg/L 5AVA (yield of 1.5 mmol/mol), whereas the C. 
glutamicum BE strain harboring pJS30 produced 12.4 g/L 
l-lysine (yield of 258.2 mmol/mol) and 641 mg/L 5AVA 
(yield of 16.7  mmol/mol) from glucose. These results 
demonstrate that heterologous expression of the davAB 
genes from gram-negative P. putida correctly functioned 
to produce 5AVA from glucose using l-lysine as a 5AVA 
precursor in gram-positive C. glutamicum.
Although the C. glutamicum BE strain harboring 
pKCA212davAB or pJS30 successfully produced 5AVA 
Fig. 1 Metabolic engineering strategies for 5AVA production using C. glutamicum. Heterologous expression of the P. putida davB gene (encoding 
l-lysine 2-monooxygenase) and the davA gene (encoding delta-aminovaleramidase) results in conversion of l-lysine into 5AVA. 5AVA5, 5-aminovaler-
ate; ASP5 l-aspartate; ASP-P aspartyl phosphate; ASP-SA aspartate semialdehyde; LYS l-lysine
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from glucose, most of l-lysine was not converted into 
5AVA, which suggests that metabolic flux from l-lysine 
to 5AVA was still quite weak as a result of inefficient 
expression of the davAB genes. Thus, we investigated 
whether 5AVA production could be enhanced by employ-
ing C. glutamicum codon-optimized davAB genes. The C. 
glutamicum BE strain harboring pJS38, which expresses 
C. glutamicum codon-optimized davAB genes, produced 
3.0  g/L 5AVA in flask cultivation, which represented an 
increase of almost 370  % over that produced by the C. 
glutamicum BE strain harboring pJS30 (Fig. 2). However, 
7.9 g/L l-lysine still remained in the culture medium of 
C. glutamicum BE strain (pJS38). The yield for l-lysine 
obtained by C. glutamicum BE (pJS38) was 193.9 mmol/
mol glucose, whereas that for 5AVA was 92.3 mmol/mol 
glucose.
Notably, 0.14  mg/L glutaric acid was detected in the 
culture medium of C. glutamicum BE (pJS38), even 
though 5AVA aminotransferase and glutarate-semial-
dehyde dehydrogenase (encoded by davT and davD, 
respectively), which are the key enzymes for further con-
version of 5AVA into glutaric acid using α-ketoglutarate 
as an amine acceptor [18, 21], were not expressed in this 
strain. This result strongly suggests that endogenous 
enzymes homologous to 5AVA aminotransferase and 
glutarate-semialdehyde dehydrogenase might be involved 
in further conversion of 5AVA into glutaric acid in C. 
glutamicum.
Examination of 5AVA production by engineered C. 
glutamicum strain expressing the davAB genes under the 
control of the tac promoter in fed‑batch fermentation
We then investigated the capability of C. glutamicum BE 
(pJS38) to produce 5AVA by fed-batch fermentation in 
a 5-L fermentor (Fig.  3a, c) to examine its potential for 
large-scale production of 5AVA. During fed-batch culti-
vation of C. glutamicum BE (pJS38), l-lysine concentra-
tion reached 21.8 g/L after 94 h of cultivation, and then 
decreased beyond this point. C. glutamicum BE (pJS38) 
produced 17.8 g/L 5AVA in 191 h, with an overall yield 
and productivity of 0.07  g/g (107.3  mmol/mol) and 
0.09 g/L/h, respectively (Fig. 3c). The total input of glu-
cose was 790  g (4.4  mol), and the total amount of pro-
duced 5AVA was 55.3 g (471 mmol), with the final volume 
of 3.1 L. The maximum specific growth rate was 0.23 h−1, 
and the observed maximum specific productivity was 
9.2  mg/g/h. Initial increases in l-lysine levels followed 
by a decrease in titer along with constant production of 
5AVA indicated that l-lysine-production flux might be 
strong initially before slowing down in the latter half of 
cultivation. The maximum l-lysine-specific productiv-
ity was 56.7  mg/g/h initially, but gradually decreased to 
Fig. 2 Growth and production characteristics of the C. glutamicum BE strain harboring the pKCA212davAB, pJS30, or pJS38 vectors after 44 h of 
shake-flask cultivation (n = 3, error bars = SD). The C. glutamicum BE strain containing no plasmids was used as a non-engineered control. a The 
final OD600 at the end of cultivation is shown for all strains tested, and an experimentally determined correlation factor (0.28) was used to determine 
the biomass yield (YX/S). b The production characteristics include the final titers for l-lysine (light-grey bars), 5AVA (dark-grey bars), and glutaric acid 
(black bars). c The molar yields from glucose for l-lysine (white bars), 5AVA (grey bars), and glutaric acid (black bars) are also shown. When appropriate, 
gene expression was induced by addition of IPTG at a final concentration of 0.5 mM when the growth reached an OD600 of 0.5–0.6
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zero. The amount of the major byproduct, glutaric acid, 
also increased steadily throughout the entire cultivation 
period until the concentration reached 5.3 g/L at the end 
of cultivation (Fig. 3c).
The maximum OD600 reached was 95.4, corresponding 
to the measured dry cell weight concentration of 24.5 g/L, 
after 189 h of fermentation (Fig. 3a). These results dem-
onstrated that C. glutamicum BE (pJS38) was able to 
successfully produce 5AVA from renewable resources 
in a laboratory-scale bioreactor. However, conversion 
of l-lysine toward 5AVA needs to be further enhanced 
through stronger expression of the davAB genes.
Construction of engineered C. glutamicum strain 
expressing the davAB genes under the control 
of constitutive promoters to improve 5AVA production
In addition to the tac promoter used in pEKEx1, promot-
ers for SOD (NCgl2826; E.C. 1.15.1.1) and the transcrip-
tion factor Tu (Tuf; Ncgl0480; E.C. 3.6.5.3) have also been 
widely used in metabolic engineering of C. glutamicum 
because of their capabilities to support strong gene 
expression at the chromosome level [34]. Although 
the sod promoter is known to exhibit weaker plasmid-
based expression than the tac promoter [35], weak and 
medium-strength expression driven by constitutive pro-
moters might be more effective than higher expression 
levels for producing chemicals of interest under differ-
ent circumstances [15]. Moreover, use of the constitutive 
promoters circumvents the requirement for costly addi-
tives such as IPTG. Therefore, we replaced the lacIQ gene 
and tac promoter in pJS38 with Psod or Ptuf (Additional 
file 5: Table S1). These constructs were then introduced 
into the C. glutamicum BE strain, and their functions 
were investigated by flask cultivation. However, expres-
sion of the davAB genes under control of the sod pro-
moter (pJS59) and tuf promoter (pJS60) did not result 
in higher 5AVA production relative to that produced 
by the parent construct, pJS38 containing the tac pro-
moter (Figs. 2, 4). C. glutamicum BE (pJS59) and C. glu-
tamicum BE (pJS60) produced 556 and 587 mg/L 5AVA, 
Fig. 3 Production of 5AVA from glucose by fed-batch cultures of (a, c) C. glutamicum BE (pJS38) and (b, d) C. glutamicum BE (p36davAB3). Charac-
teristics of the fed-batch cultivation profile, including growth (filled circles, OD600), residual sugar (empty circles; g/L), l-lysine (filled diamonds), 5AVA 
(magenta diamonds), and glutaric acid (green triangles) production titers, are plotted against the cultivation time
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respectively, with no glutaric acid observed in the culture 
media after 44 h of flask cultivation.
We also investigated the newly designed synthetic pro-
moter active in C. glutamicum, the H36 promoter [36], 
to see if it can possibly improve 5AVA production; it was 
successfully employed for the expression of glutamate 
decarboxylase (GAD) and lysine decarboxylase (LDC) 
in C. glutamicum strains, resulting in high-level produc-
tion of gamma-aminobutyrate (GABA) and cadaverine, 
respectively [30, 37].
We replaced the lacIQ and the tac promoter in pJS38 
with the PH36 promoter to construct p36davAB2. 
However, cultivation of C. glutamicum BE harbor-
ing p36davAB2 also did not improve 5AVA production, 
which resulted in production of 661  mg/L 5AVA under 
the same culture condition (Fig.  4). These results indi-
cate that expression of the davAB genes was still not 
strong enough to enable efficient conversion of l-lysine 
to 5AVA.
To continue exploring expression vector systems for 
possible improvement of 5AVA titer, we noticed that the 
strong H36 promoter originally developed with a dif-
ferent backbone vector, pCES208 [36, 38], might not be 
optimal for pEKEx1. Engineered C. glutamicum strains 
harboring a pCES208-based plasmid for expression of 
target genes under strong synthetic promoters, such as 
H30 and H36, have been reported to efficiently produce 
GABA and cadaverine from renewable resources [30, 
37]. Therefore, we transferred codon-optimized versions 
of the davAB genes into the pCES208 vector system. 
The new construct, p36davAB1, was further modified by 
inserting a His6-Tag into the N-terminal of davA gene, 
resulting in p36davAB3. This was done because there 
have been reports showing that His6-tagged constructs 
can sometimes be expressed more efficiently [39, 40]. 
These constructs were transformed into the C. glutami-
cum BE strain and assessed by flask cultivation. Whereas 
C. glutamicum BE (p36davAB1) produced only 0.4  g/L 
5AVA along with 11.7  g/L l-lysine, C. glutamicum BE 
(p36davAB3) produced 6.9  g/L 5AVA, with 5.5  g/L 
l-lysine remaining unconverted (Fig. 5). The 5AVA con-
centration obtained represents a 130  % increase over 
that (Fig.  2) obtained with C. glutamicum BE (pJS38). 
Interestingly, the construct containing the His6-tagged 
variant produced substantially more 5AVA compared to 
that produced using the construct lacking the His-tag, 
possibly because of the improved stability afforded by 
the 5′ modification, which resulted in higher expression 
of the davAB genes in the recombinant C. glutamicum 
BE strain (Additional file  1: Figure S1). Comparison of 
mRNA folding energies (ΔG) with the RNA secondary 
structure prediction program Mfold (http://unafold.rna.
albany.edu/?q=mfold/download-mfold) suggested that 
the ΔG for the first 30 nucleotides starting from the +1 
site of the H36 promoter in p36davAB2 is −6.00  kcal/
mol, which is much lower than ΔG of −0.06  kcal/mol 
obtained in p36davAB3. The higher ΔG in p36davAB3 
indicates that less stable mRNA produced by p36davAB3 
might allow the translation machinery to bind more eas-
ily than much stable mRNA produced by p36davAB2.
Fig. 4 Growth and production characteristics of the C. glutamicum BE strain harboring the pJS59, pJS60, or p36davAB2 vector after 44 h of shake-
flask cultivation (n = 3, error bars = SD). The C. glutamicum BE strain containing no plasmids was used as a non-engineered control. a The final 
OD600 at the end of cultivation is shown for all strains tested, and an experimentally determined correlation factor (0.28) was used to determine the 
biomass yield (YX/S). b The production characteristics include the final titers for l-lysine (light-grey bars), 5AVA (dark-grey bars), and glutaric acid (black 
bars)
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Examination of 5AVA production by engineered C. 
glutamicum expressing the davAB genes under the control 
of the strong H36 promoter in fed‑batch fermentation
Having achieved improved 5AVA production in flask cul-
ture, fed-batch culture of C. glutamicum BE (p36davAB3) 
was performed next in a 5-L fermentor. C. glutamicum 
BE (p36davAB3) produced 19.7  g/L 5AVA in 157  h, 
with the overall yield and productivity of 0.08  g/g and 
0.16  g/L/h, respectively (Fig.  3d). This strain also accu-
mulated 13.4 g/L glutaric acid as a byproduct at the end 
of the cultivation. On the other hand, l-lysine accumu-
lation decreased significantly compared to that observed 
with C. glutamicum BE (pJS38). l-Lysine accumulated to 
3.7 g/L in 25 h, but production remained between 1 and 
2  g/L over the entire cultivation period (Fig.  3d). Citric 
acid was another major byproduct, but its concentra-
tion remained at ~1  g/L throughout cultivation. Nota-
bly, the production patterns observed during fed-batch 
fermentation were different from those observed dur-
ing flask cultivation. Although large portions of l-lysine 
remained unconverted at the end of the flask cultivation, 
very little l-lysine remained in fed-batch fermentation. 
This indicates that control of pH and provision of suf-
ficient air streams were beneficial for 5AVA production 
and provided better results during fed-batch fermenta-
tion. A sufficient air supply is important for cultivation 
because lack of sufficient air can result in accumulation 
of substantial concentrations of lactic and acetic acids in 
the fermentation broth [30, 41]. These byproducts were 
not observed in our cultivation conditions, contrary to 
previous reports. These results suggest that the strategy 
combining improved expression of the davA gene fused 
with His6-Tag at its N-Terminal and the davB gene as an 
operon under control of the strong synthetic H36 pro-
moter was successful in directing most of the l-lysine 
pool toward 5AVA, resulting in efficient production of 
5AVA.
Construction of an engineered C. glutamicum gabT mutant 
for enhanced production of 5AVA with greatly reduced 
glutaric acid production
While 19.7 g/L of 5AVA could be produced by fed-batch 
cultivation of C. glutamicum BE (p36davAB3), glutaric 
acid, a major byproduct, was still produced to a relatively 
high concentration (up to 13.4  g/L). In order to further 
enhance 5AVA production, conversion of 5AVA into 
glutaric acid should be minimized. However, no enzyme 
responsible for converting 5AVA into glutaric acid is 
known in C. glutamicum. Thus, we performed molecular-
docking simulations, which suggested possible interac-
tions between endogenous GabT and 5AVA (Additional 
file  2: Figure S2, Additional file  3: Figure S3). GabT 
shares homology (60  % by primary peptide structure) 
with 4-aminobutyrate aminotransferase (SGR_1829) in 
Streptomyces griseus, which exhibits 60  % relative ami-
notransfer activity for 5AVA [42]. Although the pyri-
doxal phosphate moiety was in the correct orientation 
and position, the orientation of bound 5AVA was twisted, 
possibly because of the larger size of the substrate being 
accommodated in the active site. Additionally, the 
enzyme also shared high homology (Additional file  3: 
Figure S3) with P. putida DavT, which binds 5AVA as its 
natural substrate (Additional file 4: Figure S4). The major 
difference in active sites between GabT and DavT is that 
Fig. 5 Growth and production characteristics of the C. glutamicum BE strain harboring p36davAB1 or p36davAB3 after 44 h of shake-flask cultiva-
tion (n = 3, error bars = SD). a The final OD600 at the end of cultivation is shown for the strains tested. b The production characteristics include the 
final titers for l-lysine (light-grey bars), 5AVA (dark-grey bars), and glutaric acid (black bars)
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DavT contains a glutamine residue (Gln80) rather than 
a methionine residue, enabling accommodation of the 
ω-amino group in the binding pocket (Additional file 3: 
Figure S3). However, GabT from S. griseus, even with the 
methionine residue at this position, is sufficiently pro-
miscuous to accept 5AVA as a substrate [42]. Thus, we 
could conclude from the docking simulations that the 
endogenous C. glutamicum GabT might accommodate 
5AVA as a substrate for aminotransfer reactions, leading 
to the formation of glutaric acid.
Based on the above results, the gabT gene (E.C. 2.6.1.19, 
encoding 4-aminobutyrate aminotransferase, Ncgl0462) 
was deleted from the chromosome of C. glutamicum 
BE to construct C. glutamicum AVA2. C. glutamicum 
AVA2 produced 17.5 g/L of l-lysine by flask cultivation in 
44 h, with no residual 5AVA detected (Fig. 6). This result 
suggests that deletion of the gabT gene did not inhibit 
cell growth and l-lysine production. Plasmid p36davAB3 
was then transformed into C. glutamicum AVA2 to assess 
5AVA production. Fed-batch cultivation of engineered 
C. glutamicum AVA2 (p36davAB3) in a 5-L fermenter 
resulted in production of 33.1  g/L 5AVA with greatly 
reduced glutaric acid (2.0 g/L) and l-lysine (648.3 mg/L) 
at the end of cultivation. The overall yield and produc-
tivity obtained were 0.1  g/g glucose (163.1  mmol/mol) 
and 0.22  g/L/h, respectively (Fig.  7). Cells grew to an 
OD600 of 134 in 153 h, with a measured dry cell weight 
of 36.1 g/L, with the maximum specific growth rate was 
0.4  h−1. The maximum specific 5AVA productivity was 
65.8 mg/g/h, which gradually decreased to 22.1 mg/g/h at 
the end of cultivation. Additionally, the l-lysine concen-
tration peaked at 28 h, but remained as low as 1 g/L for 
the remainder of the cultivation. As expected, gabT dele-
tion resulted in a significant decrease in glutaric acid pro-
duction compared to that observed in the parent strain. 
However, the continued presence of glutaric acid in the 
culture broth suggests that unknown aminotransferases 
still remain in C. glutamicum that are capable of convert-
ing 5AVA to glutaric acid, although at lower efficiencies 
than GabT.
Conclusions
In this study, we report development of engineered C. 
glutamicum strains for the production of 5AVA from glu-
cose. Expression of two key enzymes, lysine 2-monooxy-
genase and delta-aminovaleramidase, was systematically 
optimized by examining different promoters, origins of 
replication, codon usage of the davAB genes, and even 5′ 
modification of the davA gene with a His-tag, all of which 
Fig. 6 Growth and production characteristics of the AVA2 strain for 
44 h of shake-flask cultivation (n = 3, error bars = SD). OD600 (filled 
circle), glucose (empty circle) and l-lysine (filled diamond) are shown
Fig. 7 Fed-batch cultivation of C. glutamicum AVA2 harboring p36davAB3 for the production of 5AVA in laboratory-scale bioreactor from glucose. 
a Characteristics of the fed-batch cultivation profile including growth (filled circles, OD600), residual sugar (empty circles; g/L) and b production titers 
of products including l-lysine (dark diamonds), 5AVA (magenta diamonds), and glutaric acid (green triangles) are plotted against the cultivation 
time
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were found to be important for determining the optimal 
and stable plasmid-based expression of the davAB genes 
in C. glutamicum. In addition, production of a major 
byproduct, glutaric acid, could be significantly reduced by 
identifying previously unknown enzyme GabT responsi-
ble for converting 5AVA to glutaric acid and deleting the 
corresponding gene from the chromosome. Fed-batch 
cultivation of the final engineered C. glutamicum AVA2 
strain harboring p36davAB3 produced 33.1  g/L 5AVA 
with greatly reduced glutaric acid (2.0 g/L). The metabol-
ically engineered C. glutamicum strains developed in this 
study should be useful for enhanced fermentative pro-
duction of the novel C5 platform chemical, 5AVA, from 
renewable resources such as glucose.
Methods
Strains and plasmids
All bacterial strains and plasmids used in this study are 
listed in Additional file 5: Table S1. All DNA manipula-
tions were performed following standard procedures 
[43]. Primers used in this study (Additional file 6: Table 
S2) were synthesized at Bioneer (Daejeon, Korea). C. glu-
tamicum BE (KCTC 12390BP) was used as the base strain 
for 5AVA production. Polymerase chain reaction (PCR) 
was performed with the C1000 Thermal Cycler (Bio-
Rad, Hercules, CA, USA). The general PCR condition for 
amplifications of target genes using primer sets listed in 
Additional file 6: Table S2 is as follows: 1 cycle of 95 °C for 
5 min; 30 cycles of 94 °C for 30 s, 52 °C for 30 s, 72 °C for 
1 min 30 s; and a final extension of 72 °C for 5 min. The 
final reaction volume is 20  μL. The in-house-developed 
C. glutamicum shuttle vector pKCA212-MCS was con-
structed by cloning the origin of replication of the cryptic 
plasmid pCC1 [33] into pKA212-MCS at the AatII and 
XhoI sites. The origin of replication of pCC1 was synthe-
sized by GenScript (http://www.genscript.com) based on 
the reported sequence. Plasmid pKA212-MCS was con-
structed by replacing the chloramphenicol-resistance 
gene of pKA312-MCS [11] with a kanamycin-resistance 
gene obtained from pZA21-MCS (http://www.expressys.
com) by restriction digest with AatII and SpeI. The davAB 
genes from pKE112-DavAB [20, 21] were restriction-
digested and ligated into pKCA212-MCS to construct 
pKCA212davAB using the same restriction enzyme sites 
(EcoRI/KpnI, KpnI/BamHI). A 16-bp untranslated region 
(tttcacacaggaaaca) containing a ribosome-binding site 
was present between the two genes for davB expression. 
The same genes were also cloned into pEKEx1 to con-
struct pJS30. The codon-optimized versions of davAB 
genes (Additional file 7: Table S3) with preferred codon 
usage in C. glutamicum were synthesized by Bioneer 
(Daejeon, Korea) and cloned into the EcoRI/BamHI 
restriction enzyme sites in pEKEx1 to yield pJS38.
To construct promoter variants of pEKEx1, promoter-
less pEKEx1 was created by removing the tac promoter 
and the initial 778  bp of the coding sequence of the 
LacIQ gene from pEKEx1 by restriction digestion with 
EcoRV/EcoRI. The desired promoters were similarly 
designed as previously described [5, 34, 44] and inserted 
into the promoterless pEKEx1 vector. The region 250 bp 
upstream of the start codon for the superoxide dismutase 
gene (NCgl2826, E.C. 1.15.1.1) was amplified by poly-
merase chain reaction (PCR) from C. glutamicum ATCC 
13032 chromosome using primers Psod_F_EcoRV and 
Psod_R_EcoRI, and then digested and cloned into the 
EcoRV/EcoRI sites of the promoterless pEKEx1 vector to 
construct pJS57. The 248-bp sequence upstream of the 
start codon for the gene encoding the elongation factor 
Tu (Ncgl0480, E.C. 3.6.5.3) was amplified by PCR from C. 
glutamicum ATCC 13032 chromosome using the primers 
Ptuf_F_EcoRV (v2) and Ptuf_R_EcoRI, and then digested 
and cloned into the promoterless pEKEx1 vector to yield 
pJS58. The codon-optimized davAB genes from pJS38 
were restriction-digested with EcoRI/BamHI and cloned 
into the pJS57 and pJS58 vectors at the EcoRI/BamHI 
restriction enzyme sites to make pJS59 and pJS60, 
respectively.
Plasmid p36davAB2 was constructed from pEKEx1 by 
cloning the codon-optimized davAB genes. Promoter-
less pEKEx1 was constructed by methods similar to 
those described in the previous paragraph, except that 
the genes were cloned into the EcoRV/PstI restriction 
sites of the vector. The PH36 promoter was amplified by 
PCR using the JW02H-F and JW02H-R primers from 
pCES208H36GFP, and the fragments were restriction-
digested with EcoRV/EcoRI. A second round of PCR 
using primers JW02AB-F and JW02AB-R from pJS38 
generated codon-optimized davAB gene fragments that 
were restriction-digested with EcoRI/PstI. The resulting 
products were then ligated into the EcoRV/PstI restric-
tion sites of the promoterless pEKEx1 vector to yield 
p36davAB2.
Plasmid p36davAB1 was constructed from pCES208 
by cloning the codon-optimized davAB genes. Products 
from the first round of PCR using primers JW01A-F and 
JW01A-R were used for amplification of the davA gene, 
which was then restriction-digested with BamHI/SfiI. 
The second round of PCR used primers JW01B-F and 
JW01B-R to amplify the davB gene, which was then 
restriction-digested with NotI. These fragments were 
cloned into the pCES208H36GFP vector [36] by replac-
ing the egfp gene to yield p36davAB1.
Plasmid p36davAB3 was constructed from the 
pCES208H36EGFP vector [36]. The codon-optimized 
davA gene fused with His6-Tag at its N-Terminal was 
amplified using primers JW03A-F and JW01A-R and 
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restriction-digested with BamHI and SfiI. The codon-
optimized davB gene was amplified using primers 
JW01B-F and JW03B-R and restriction-digested with 
NotI. The two products were then cloned into the 
pCES208H36EGFP vector by replacing the egfp gene to 
construct p36davAB3.
Plasmid pJS113 beta was constructed from the 
pK19mobsacB vector [45]. Primers 113 i1F beta and 113 
i1R beta were used to PCR-amplify the upstream region 
and a portion of the gabT gene from C. glutamicum. 
Primers 113 i2F beta and 113 i2R beta were then used to 
PCR-amplify the downstream region and a portion of the 
gabT gene of C. glutamicum. The two PCR products were 
joined by a third PCR using primers 113 i1F beta and 113 
i2R beta. The final PCR product was cloned into the PstI-
digested pK19mobsacB to make pJS113 beta. pJS113 beta 
was subsequently used to disrupt the gabT gene in the C. 
glutamicum BE chromosome, resulting in the strain C. 
glutamicum AVA2. This in-frame deletion left a 330-bp 
deletion in the 280–609 region of the 1347-bp gabT gene.
E. coli DH5α and TOP10 strains (Additional file  5: 
Table S1) were used for general cloning purposes. All 
constructed plasmids introduced into C. glutamicum, 
except for pJS113 beta, were prepared in unmethylated 
form using the methylation-deficient E. coli JM110 strain 
(Stratagene; Agilent Technologies, Santa Clara, CA, 
USA). pJS113 beta was propagated in C. glutamicum by 
bacterial conjugation using E. coli S17-1 as a donor [45]. 
Plasmids were introduced via electroporation as previ-
ously described [46]. Cells were transferred to a micro-
cuvette and electroporated using a micropulser. Cells 
were transformed with about 2 μg of DNA by electropo-
ration (1.8 V and 400 Ω). Pre-chilled preculture medium 
(900  μL) was added and the transformed cells were 
allowed for growth recovery for 2 h without shaking in a 
30 °C incubator. The transformed cells were then spread 
onto the agar plates containing kanamycin as a selective 
marker.
Culture media
Cells were cultured in media described below, the com-
positions of which were modified from previous reports 
[34, 43]. The pre-culture medium for shake-flask cultiva-
tion consisted of 10 g/L beef extract (BD Bacto, Franklin 
Lakes, NJ, USA), 40 g/L brain–heart infusion (BD Bacto), 
20 g/L d-sorbitol, and 10 g/L glucose [41]. The flask cul-
ture medium (pH 7.2) consisted of 80 g/L glucose, 1 g/L 
MgSO4, 1 g/L K2HPO4, 1 g/L KH2PO4, 1 g/L urea, 20 g/L 
(NH4)2SO4, 10 g/L yeast extract, 100 μg/L biotin, 10 mg/L 
β-alanine, 10 mg/L thiamine HCl, 10 mg/L nicotinic acid, 
1.3 mg/L (NH4)6MoO24, 40 mg/L CaCl2, 10 mg/L FeSO4, 
10  mg/L MnSO4, 5  mg/L CuSO4, 10  mg/L ZnSO4, and 
5 mg/L NiCl2.
For fermentation experiments, the seed medium (pH 
7.0) consisted of 20  g/L glucose, 1  g/L MgSO4, 10  g/L 
beef extract, 1 g/L K2HPO4, 1 g/L KH2PO4, 0.5 g/L urea, 
10 g/L yeast extract, 100 μg/L biotin, 200 μg/L thiamine 
HCl, 10 mg/L FeSO4, and 10 mg/L MnSO4. The fermen-
tation medium (1.8 L) contained per liter: 160 g of glu-
cose, 2 g of MgSO4, 2 g of K2HPO4, 2 g of KH2PO4, 2 g 
of urea, 40 g of (NH4)2SO4, 20 g of yeast extract, 50 mg 
of CaCl2, 50  μg of biotin, 20  mg of β-alanine, 20  mg 
of thiamine HCl, 20  mg of nicotinic acid, 1.3  mg of 
(NH4)6Mo7O24, 10 mg of FeSO4, 10 mg of MnSO4, 5 mg 
of CuSO4, 10  mg of ZnSO4, 5  mg of NiCl2, and 1  mL 
of antifoam reagent (Antifoam 204; Sigma-Aldrich, St. 
Louis, MO, USA). Each feeding solution (200 mL) con-
tained 90 g of glucose.
Flask cultivation
Stock cells stored in glycerol were used to inoculate 
5-mL pre-cultures, which were grown at 30  °C with 
shaking at 200  rpm in an incubator (JSSI-300C; JS 
Research Inc., Gongju, Korea) for 17–18  h. Cells sus-
pended in 250-μL aliquots of pre-culture were harvested 
by centrifugation (Centrifuge 5415 D; Eppendorf, Ham-
burg, Germany) and transferred to a 25-mL primary 
culture in autoclaved 300-mL baffled Erlenmeyer flasks, 
each containing 1.5  g of CaCO3 to maintain the pH at 
~7.0 during cultivation. Primary cultures were grown 
with shaking in an incubator for 44 h. When appropri-
ate, isopropyl-β-d-thiogalactopyranoside (IPTG) at a 
final concentration of 0.5 mM was used to induce gene 
expression during the early log phase (OD600 = 0.5–0.6), 
with 25.0 μg/mL kanamycin added for selective pressure 
(Ravasi et al. [35]).
Fed‑batch fermentation
Stock cells stored in glycerol were used to inoculate 5.0-
mL pre-cultures, which were grown at 30 °C with shak-
ing in an incubator for 17–18  h. Two 1-mL samples of 
the pre-culture were transferred to two 1-L Erlenmeyer 
flasks, each containing 100  mL of seed medium, and 
grown with shaking (200  rpm) in a 30  °C incubator for 
19–20  h. The entire seed culture (200  mL) was added 
as the inoculum to the 1.8-L primary culture in a fer-
menter (initial OD600 = 1.5–2.0 in 2 L). IPTG at a final 
concentration of 1 mM and kanamycin (25.0 μg/L) were 
also added during fermentation inoculation. A NBS Bio-
Flo 3000 fermenter system (New Brunswick Scientific, 
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Edison, NJ, USA) equipped with a 6.6-L jar was used for 
all fed-batch cultivation experiments. The pH was main-
tained at 7.0 by addition of 28 % (v/v) ammonia solution 
(Junsei Chemical Co., Ltd., Tokyo, Japan). Temperature 
and agitation were maintained at 30  °C and 600  rpm, 
respectively, by a proportional-integral-derivative con-
troller throughout the entire cultivation period. The 
aeration rate was maintained at 1  L/L/min. Foaming 
was suppressed by addition of 1:10 diluted antifoam 204 
(Sigma-Aldrich). Feeding solution (200 mL) was manu-
ally added each time the residual glucose level decreased 
to <20 g/L.
Analytical procedures
Two high-performance liquid chromatography (HPLC) 
systems, Agilent 1100 (Agilent Technologies) and Waters 
Breeze 2 (Waters Corporation, Milford, MA, USA), were 
used to determine the metabolite concentration in the 
culture broth. For detection of amino compounds, the 
supernatant of the culture samples was reacted with 
o-phthaldehyde as previously described [13] prior to 
injection into the Eclipse Zorbax-AAA column (Agi-
lent Technologies). Linear gradients of mobile phase A 
[10 mM Na2HPO4, 10 mM Na2B4O7·10H2O, and 8 mg/L 
NaN3 (pH 7.2)] and mobile phase B (methanol, acetoni-
trile, and water at a volumetric ratio of 45:45:10) were 
used to separate the amino acids in the column. Borate 
buffer (0.4  M; pH 10.2) was used as a buffering agent 
rather than pH 9.0 buffer as previously described [13]. 
The derivatized compounds were detected using a diode-
array detector at 338  nm. The column temperature was 
set to 25  °C, and the flow rate of the pump was set to 
0.640  mL/min. The following gradient was applied for 
resolving the compounds: 0–0.5 min, 0 % B; 0.5–18 min, 
a linear gradient of B from 0 to 57 %; 18–26 min, a lin-
ear gradient of B from 57 to 100 %; 26–31.8 min, 100 % 
B; 31.8–31.9 min, a linear gradient of B from 100 to 0 %; 
31.9–32 min, 0 % by volume. Glutaric acid was detected 
using the Waters Breeze 2 HPLC system (Waters Corpo-
ration) with a MetaCarb 87H column (Varian; Crawford 
Scientific, Strathaven, UK) and a constant flow of sulfuric 
acid solution at 0.5 mL/min. The Waters Breeze 2 system 
included an isocratic pump (Waters 1515; Waters Corpo-
ration), a refractive index detector (Waters 2414; Waters 
Corporation), and an autosampler (Waters 2707; Waters 
Corporation).
Cell growth was monitored by measuring the OD600 
with an Ultrospec 3000 spectrophotometer (Amersham 
Biosciences, Uppsala, Sweden). The correlation fac-
tor (0.28  g of dry weight of cells per L per OD600 of 1) 
was experimentally determined and used for biomass 
concentration calculation of flask-cultivated cells. This 
correlation factor was in agreement with a previously 
reported value [47]. Glucose concentration was meas-
ured using a 2700 biochemistry analyzer (YSI, Yellow 
Springs, OH, USA). When necessary, diluted HCl solu-
tion was used to neutralize CaCO3 in the cultivation 
media.
Molecular docking simulation
Molecular docking simulations were performed 
using Autogrid and Autodock 4.2.5.1 software [48]. 
Gasteiger charges and hydrogen atoms were added 
using AutoDockTools 1.5.6. A Lamarckian genetic 
algorithm with default parameters was used, and no 
peptide residues were kept flexible. The docking grid 
was set to encompass the catalytic pocket, but not the 
entire enzyme. For docking of the natural substrate of 
4-aminobutyrate aminotransferase, the substrate mol-
ecules were separately saved from a known structure 
(PDB ID: 4ATQ) [49] as a single molecule in the form 
of an external aldimine and used as a ligand. For dock-
ing with 5AVA aminotransferase, pyridoxal phosphate 
and 5AVA in the form of an external aldimine were 
used as the ligand. Torsion about the bond between 
the pyridine moiety of the pyridoxal phosphate and the 
Schiff base was not allowed during docking. The dock-
ing results were visualized using PyMol 1.6 (https://
www.pymol.org/pymol) without additional hydrogen 
atoms.
Molecular modeling
Homology modeling was carried out with SWISS-
MODEL [50]. 4-Aminobutyrate aminotransferase (E.C. 
2.6.1.19) of C. glutamicum was homology modeled 
using the same enzyme from A. aurescens (PDB ID: 
4ATQ chain B) [49] as a template. A minor correction 
was applied for this model (Additional file 2: Figure S2) 
based on a different enzyme structure (PDB ID: 3LV2). 
The same enzyme from S. griseus was homology mod-
eled using that from Mycobacterium smegmatis (PDB 
ID: 3Q8  N chain D) as a template. 5-Aminovalerate 
aminotransferase (E.C. 2.6.1.48) of P. putida KT2440 
was homology modeled using 4-aminobutyrate ami-
notransferase from E. coli (PDB ID: 1SFF chain A) [51] 
as a template.
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